Search Results

Discover key 2024 trends shaping the dossier industry, from portfolio reassessments to ESG expectations and serialization. Learn how Medis is leading with innovative strategies to meet global demands.

Meet the Medis Scientific and Technical Affairs Team, a collective of experts offering specialized support in complex pharmaceutical matters, aiming to ensure successful dossier submissions, marketing authorization approvals, and continuous product supply. Discover their integral role in enhancing Medis' out-licensing capabilities through their expertise in regulatory affairs, serialization, and commercial support in the global pharmaceutical market.

Our experts are getting ready to connect at the CPhI Festival of Pharma in October.

We are delighted to share with you that Medis has been named as a finalist at the CPhI 2019 Awards, for “Excellence in Pharma: Regulatory Procedures and Compliance”, in relation to our exemplary work around Serialization.